Skip to content
Saturday, June 7, 2025
Latest:
  • Learning that lifts us all: Insights from a year of growth and professional development
  • A novel source of genetic variation influencing childhood brain tumors
  • Beyond the operating room: How international training elevates orthopedic care
  • Innovation resident plays key role in groundbreaking heart device research
  • Alzheimer’s disease affects an organism as a whole
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
From The Labs

Understanding the cancer risk in children with birth defects

June 25, 2020 ALL,  Birth defects,  cancer risk,  hepatoblastoma,  neuroblastoma,  pediatric oncology,  Research

Understanding the cancer risk in children with birth defects has been a challenge. Although scientific studies suggest that birth defects increase the risk of cancer,

Read More
From The Labs

Trading a spear for a trident is promising in the fight against leukemia

April 14, 2020 ALL,  CART cells,  CD19,  CD20,  CD22,  pediatric leukemia,  Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. While most children respond well to chemotherapy, some experience resistant or relapsed disease. Building on

Read More
Jeremy-Schraw-photo
From The Labs

From my perspective: Dr. Jeremy Schraw shares his experiences during postdoctoral training

December 10, 2019 ALL,  From my perspective,  metabolomics,  Pediatric Cancer,  postdoc,  Research

From the Labs interviewed Dr. Jeremy Schraw to learn about his experiences during his postdoctoral training at Baylor College of Medicine and Texas Children’s Hospital.

Read More
From The Labs

Applying basic science helps predict poor treatment outcomes in ALL

November 21, 2019 Acute Lymphoblastic Leukemia,  ALL,  carbon metabolism,  metabolome,  Pediatric Cancer,  prognosis,  Research

The survival of patients with pediatric acute lymphoblastic leukemia (ALL) has significantly improved in the last several decades, but there is still a group of

Read More
From The Labs

Exploring the risk of ALL in children with Down syndrome

September 24, 2019 Acute Lymphoblastic Leukemia,  ALL,  CDKN2A gene,  Childhood leukemia,  Down syndrome,  IKZF1 gene,  Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951